Finasteride affects the hormones involved with male pattern baldness. Finasteride may help slow hair loss at your hairline, ...

Two phase 3 trials for clascoterone have shown significant improvements in patients’ hair counts. One study showed a ...

Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...

Not only did lab tests prove that the minoxidil was being absorbed more readily in mouse test-subjects with the support of ...

Strong trial data has rewritten Cosmo’s prospects, but the real test lies ahead as regulators, partners and patients decide ...

For years, desi ghee and garlic have been prized in Indian kitchens, not only for adding flavour to food but for their ...

A new experimental scalp treatment called clascoterone has shown strong results in helping reduce male-pattern hair loss (also known as androgenetic alopecia, or AGA). Experts call the results ...

Researchers, like those at Durham University, are playing a key role by analyzing bird data that helps reveal where ...

A common acne medication may soon offer hope to millions of men struggling with hair loss. Ireland-based pharmaceuticals reported that clascoterone, a topical drug originally approved for acne, ...

Clascoterone: Male pattern baldness, androgenic alopecia, is one of the most common forms of hair loss among men, often appearing in their late 20s or early 30s. The condition leads to permanent hair ...

Readers wrote in about rules for government assistance, wind farms and AI in letters published Dec. 29, 2025, to Jan. 4, 2026 ...

Cosmo Pharmaceuticals' new drug, clascoterone, shows encouraging phase 3 results in treating male baldness, potentially revolutionising hair loss treatments.